Annika Strönisch

Mrs. Annika Strönisch

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2023 in Life
Verified
Journal Article
Open access
PDF file
ASAnnika Strönisch
Annika Strönisch
Sven MaerdianSven Maerdian
Sven Maerdian
Anne FlörckenAnne Flörcken
Anne Flörcken
Sarcoma treatment requires a high level of expertise due to its rarity and heterogeneity. Sarcoma patients should, therefore, be referred to an expert centre as early as possible to ensure optimal treatment. Numerous studies have been carried out to provide evidence for this strategy. In compliance with the 2020 PRISMA guidelines, a systematic search was conducted in PubMed, EMBASE, Ovid Medline, ClinicalTrials.gov and Cochrane Library databases. The subject of these studies was the centralised treatment of adult sarcoma patients at expert centres and the use of interdisciplinary tumour boards. Uncertainty in therapy, delays in referral to expert centres, and limited access to therapeutic modalities continue to be a challenge in sarcoma therapy. At expert centres, diagnostic procedures were more frequently and adequately performed, and treatment was associated with an improvement in outcomes in the majority of studies: patients benefited from longer survival, lower local recurrence rates and a better postoperative outcome. The implementation of an interdisciplinary tumour board was associated with discrepant results. In a greater number of studies, it was associated with a lower local relapse rate, better overall survival and surgical outcome. In two studies, however, a shorter overall survival was observed. The establishment of expert centres and the consistent use of interdisciplinary tumour boards are important structures for ensuring multidisciplinary therapy approaches. There is growing evidence that this holds great potential for optimising sarcoma therapy.

1 November 2021 in Journal of Biomechanics
Verified
Journal Article
Closed access
RSRosa Bianca Schmuck
Rosa Bianca Schmuck
ELEvi Lippens
Evi Lippens
DWDag Wulsten
Dag Wulsten
DGDaniela S. Garske
Daniela S. Garske
ASAnnika Strönisch
Annika Strönisch
ACAmaia Cipitria
Amaia Cipitria

16 October 2024 in International Journal of Cancer
Verified
Journal Article
Open access
ASAnnika Strönisch
Annika Strönisch
DRDaniel Rau
Daniel Rau
SWSilvan Wittenberg
Silvan Wittenberg
DKDavid Kaul
David Kaul
GKGeorgios Koulaxouzidis
Georgios Koulaxouzidis
Anne FlörckenAnne Flörcken
Anne Flörcken
Centralising soft tissue sarcoma (STS) treatment in expert centres and implementing comprehensive therapy concepts through interdisciplinary tumour boards (ITB) has led to significant treatment progress. However, our knowledge on the implementation of the ITB recommendations and its impact on patient outcome is limited. In this retrospective analysis, we examined a cohort of 222 adult patients (pts) with primary STS who were presented to the ITB of the Charité Comprehensive Cancer Centre between 2015 and 2020. In localised disease (n = 188), resection was recommended in 71% (n = 134) of pts. The treatment modalities chemotherapy with or without regional deep hyperthermia, and radiotherapy were recommended in 37% (n = 69), 26% (n = 48) and 52% (n = 97), respectively. Complex multidisciplinary concepts were established in 29% (n = 54) including ≥3 treatment modalities. Only partial adherence, either by choice of patient or treating physician, was associated with a higher risk of both progression (HR 4.0 95%‐CI 1.6–9.7 p < .01) and mortality (HR 5.3 95%‐CI 1.7–16.4 p < .01). Pts inable to follow the ITB recommendations due to complications or rapid progression showed a high‐risk profile with increased mortality and progression rates (HR 18.1 95%‐CI 8.5–38.2 p < .001; HR 21.5 95%‐CI 8.5–54.7 p < .001). To our knowledge, this represents the first German Comprehensive Cancer Centre analysis of therapy adherence in STS. It provides further real‐world evidence that full adherence to ITB recommendations and the ability to adhere to them are of prognostic value for patient outcome and underlines the importance of interdisciplinary decision‐making and treatment planning for STS patients.